Skip to main content

Table 1 Characteristics of the study groups

From: Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris

  Group IA (n = 15) Group IB (n = 20) Group II (n = 10) Group III (n = 10)
Mean age (yr) 57.7 ± 10.2 57.8 ± 8.7 53.3 ± 7.4 56.8 ± 11.8
Male sex (%) 86 90 40 40
DM (%) 13 25 0 0
Current smoker (%) 80 45 60 70
HT (%) 60 35 70 30
BMI 33.7 ± 6.8 28.9 ± 4.5 26.1 ± 2.5 26.3 ± 3.1
WBC (/mm 3 ) 9044 ± 2097 8685 ± 2541 6200 ± 964 6530 ± 1240
ESR (mm/hr) 28.3 ± 16.2 22.4 ± 14 6.7 ± 1.9 8.5 ± 1.8
TC (mg/dl) 209.9 ± 69.1 181.2 ± 31.6 199.2 ± 46.5 200 ± 38.2
TG (mg/dl) 202 ± 120 156.8 ± 86.4 101.9 ± 32 113.6 ± 41.7
HDL-C (mg/dl) 40.5 ± 13 41.4 ± 9.9 32.8 ± 4.2 41.1 ± 9.8
LDL-C (mg/dl) 119 ± 47 109 ± 26.6 102.7 ± 24 107 ± 37.5
Extent of CAD     
1 vessel (%) 0 20 70 0
2 vessel (%) 54 20 30 0
3 vessel (%) 46 60 0 0
  1. Group IA: Patients with unstable angina pectoris and tirofiban infusion, Group IB: Patients with unstable angina pectoris but no tirofiban infusion, Group II: Patients with stable angina pectoris, Group III: patients with normal coronary angiography, DM: Diabetes mellitus, HT: Hypertension, BMI: Body mass index, WBC: White blood cell, ESR: Erythrocyte sedimentation rate, TC: Total cholesterol, TG: Triglyceride, HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein cholesterol, CAD: Coronary artery disease.